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ABSTRACT 
This study was conducted to examine the rate of  Mycobacterium tuberculosis infection among individuals attending 
the outpatient clinic of two hospitals in Abeokuta Metropolis in Southwestern Nigeria. Of the 132 individuals 
examined, the overall rate of tuberculosis infection was 16.7%. Infection was highest among patients in the 21-40 year 
age group (11.4%). Results also showed that 10.6% of male patients were infected with tuberculosis and 6.1% of female 
patients infected with tuberculosis. There was no significant difference between the sex and Mycobacterium 
tuberculosis infection. There was also no significant difference between age-groups and Mycobacterium tuberculosis 
infection. But there was a significant difference between the ESR and tuberculosis infection. 
 
PREVALENCE DE TUBERCULOSE PARMI LES PATIENTS SUIVIS DANS DEUX 
HOPITAUX DE SOINS SECONDAIRES DE ABEOKUTA, ETAT DE OGUN 
1Babajide TI, 2Nwadike VU, 1Ojo DA, 3Onasanya OA, Ojide KC, Kalu IE 
1. Département de Microbiologie, Université  Fédéraled’Agriculture, Abeokuta. 2. Division de Microbiologie 
Médicale 
Département de Pathologie de CentreFédéralMédical,  Abeokuta. 3. Département de Santé publique et alliés, Babcock 
Université d’Ilishan, Etat d’Ogun.  Département de Microbiologie Médicale, FTH Abakaliki. 5. Départementde 
Microbiologie Médicale, FMC Umuahia. 
Adresse de correspondent: email: victornwadike@yahoo.co 
Résumé 
Cette étude a été menée afin d’examiner le taux d’infections à Mycobacteriumtuberculosischez les individus suivis à la 
clinique externe de deux hôpitaux de métropole de Abeokuta au Sud-ouest du Nigéria. Sur les 132 individus 
examinés, le taux global d'infection de la tuberculose était de 16,7%. L'infection était plus élevée chez les patients âgés 
de 21-40 ans (11,4%). Les résultats ont également montré que 10,6% des patients de sexe masculin ont été infectés par 
la tuberculose et 6,1% des patientes infectées par la tuberculose. Il n'y avait pas de différence significative entre le 
sexe et l'infection à Mycobacteriumtuberculosis. Il n'y avait pas de différence significative entre les groupes d'âge et 
l'infection à Mycobacteriumtuberculosis. Mais il y avait une différence significative entre l'ESR et la tuberculose. 
 
INTRODUCTION 
Tuberculosis (TB) is an infectious disease caused 
by the bacterium Mycobacterium 
tuberculosis. It was first  
described in 1882 by Robert Koch, who won the 
Nobel Prize in Physiology/ Medicine for 
this discovery in  
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1905 (1). It essentially attacks the lungs in more 
than 80% of the cases, leading to primary 
tuberculosis.  
Extra-pulmonary tuberculosis occurs in less than 
20% of cases and affects various organs 
such as lymph  
nodes, meninges, intestine, bone and joints 
among others( 2).  
 
Tuberculosis is an infectious disease causing 
mortality in humans. Timely detection of 
the disease permits  
the institution of effective, life-saving treatment, 
and thereby reduces transmission to close 
contacts. Despite  
the technical advancement in tuberculosis 
research, improved environmental 
conditions especially in the  
developed countries and the discovery of 
effective treatment half a century ago, the 
disease remains a health  
problem worldwide (3). M. tuberculosis infection 
remains the leading infectious killer of 
youth and adults.  
Tuberculosis (TB) is the leading cause of death in 
the world from a bacterial infectious 
disease. The disease  
affects 1.8 billion people per year which is equal 
to one-third of the entire world population 
(4). 
 
Mycobacterium tuberculosis, along with M. bovis, 
M. africanum and M. microti all cause the 
disease known as  
tuberculosis and are members of the 
Mycobacteria tuberculosis complex. Each 
member of the complex is  
pathogenic, but Mycobacterium tuberculosis is for 
humans while Mycobacterium bovis is 
usually pathogenic for  
animals (5). Tuberculosis usually attacks the 
lungs but can also affect other parts of the 
body. It is spread  
through droplet or aerosol (6). 
 
M. tuberculosis is classified as an acid fast 
bacterium and it divides every 15- 20 
hours, which is slow when  
compared to other bacteria, which tend to have 
division times measured in minutes. It’s a 
small, rod-like  
bacillus that can withstand weak disinfectants 
and can survive in dry state for weeks (7). 
Mycobacterium  
tuberculosis is identified microscopically by its 
staining characteristics; it retains stains 
after being treated  
with acidic solution, and is thus classified as an 
acid fast bacillus (AFB). In Ziehl-Neelsen 
staining  
procedure, AFB are stained a bright red, and can 
also be visualized by fluorescent 
microscopy and diagnosis  
can be made using polymerase chain reaction 
(PCR) (8). 
 
Most infections in humans result in an 
asymptomatic, latent infection and about 
one in ten latent infections  
eventually progresses to active disease which if 
left untreated, kills more than 50% of its 
victims. 
The classic symptoms are a chronic cough with 
blood-tinged sputum, fever, night sweats, 
and weight loss  
(the last giving rise to the formerly prevalent 
colloquial term "consumption"). Infection 
of other organs  
causes a wide range of symptoms (9). Diagnosis 
relies on radiology (commonly chest X-
rays), a skin  
test, blood tests, as well as microscopic 
examination and microbiological culture of 
bodily fluids. Treatment  
is difficult and requires long courses of multiple 
antibiotics. Contacts are also screened and 
treated if  
necessary (6).  Antibiotic resistance is a growing 
problem in (extensively) multi-drug-
resistant tuberculosis.  
145 
  
Prevention relies on screening programs and 
vaccination, usually with Bacillus 
Calmette-Guérin vaccine  
(10). 
Although, one third of the world's population is 
thought to be infected with M. tuberculosis 
(11), new  
infections occur at a rate of about one per second 
(12). The proportion of people who become 
sick with  
tuberculosis each year is stable or falling 
worldwide but, because of population 
growth, the absolute  
number of new cases is still increasing (12). In 
2007 there were an estimated 13.7 million chronic 
active cases, 9.3 million new cases, and 1.8 
million deaths, mostly in developing countries 
(13). In addition, more people in the developed 
world are contracting tuberculosis because their 
immune systems are compromised by 
immunosuppressive drugs, substance abuse, or 
AIDS. The distribution of tuberculosis is not 
uniform across the globe; about 80% of the 
population in many Asian and African countries 
test positive in tuberculin tests, while only 5-10% 
of the US population test positive (14).In another 
study conducted in umuahia by Nwachukwu et 
al it was  reported that the overall prevalence of 
M. tuberculosis infections was 21.6% (15). The 
objective of this study is to determine the 
prevalence of tuberculosis among patients using 
two major hospitals in Abeokuta, Ogun State. 
MATERIALS AND METHODS 
STUDY AREA 
The study was conducted in Abeokuta, the 
capital city of Ogun State, Southwest Nigeria.   
The hospitals selected for this study were Sacred 
Heart Hospital, Lantoro and State General 
Hospital, Ijaiye, Abeokuta. The hospitals were 
selected because they are reference centers for the 
diagnosis and treatment of tuberculosis (TB). 
SAMPLE COLLECTION 
The samples were collected randomly among 
suspected TB patients attending the outpatient 
clinic at Sacred Heart Hospital, Lantoro and State 
General Hospital, Ijaiye, Abeokuta within the 
period of March to April, 2011. The samples 
collected were blood and sputum. 
Sputum Collection 
One hundred and thirty two sputum samples 
were collected for this study. Three sputum 
specimens were collected from each patient. 
These were ‘first spot’ specimen, an early 
morning specimen and a ‘second spot’ specimen. 
The selected patients were given two dry clean, 
universal containers each. They were instructed 
to produce sputum from a deep cough into one 
of the containers on the first day of visitation to 
the clinic (first spot specimen). The patients took 
the second container home and were instructed 
to produce early morning sputum from a deep 
cough before food (early morning specimen). On 
arrival to the laboratory with the early morning 
specimen, another sputum specimen (second 
spot specimen) was collected from each patient. 
MICROSCOPIC EXAMINATION OF THE 
SPUTUM 
Equal volume of sputum specimen and 4% 
sodium hydroxide were mixed together, 
centrifuged at 3000 rev/ min for 15 minutes and 
a wooden applicator was used to transfer an 
appropriate part of the sediment onto the slide 
and smeared in a repeated coil type on the 
middle of a clean microscope slide over an area 
approximately 2cm by 1cm. The smear was 
allowed to dry on the bench for 15 minutes and it 
was fixed by passing through flame 3-4 times 
with the smear uppermost. The fixed smear was 
flooded with Ziehl-Neelsen Carbol Fuchsin and 
slide was heated slowly until it was steamed. 
Steaming was maintained for 3-5 minutes by 
using low or intermittent heat. The slide was 
rinsed in a gentle stream of running water until 
the excess stain is washed away. The slide was 
flooded with decolorizing solution (3% acid-
alcohol) and it was left for 3 minutes. The slide 
was rinsed thoroughly with water and excess 
was drained. The slide was flooded with 
methylene blue to counter stain and was left for 1 
minute. The slide was rinsed thoroughly with 
water and excess water was drained. The slide 
was allowed to air dry and was viewed under the 
oil immersion microscope. The results of sputum 
examination can either be positive or negative. 
Positive results include: 1+, 2+ and 3+ 





TABLE 1: INTERPRETATION OF RESULTS 
(0): means no AFB is seen in at least 100 
fields, therefore it’s reported as negative. 
(1+): means 10-99 AFB are seen in 100 fields. 
(2+): means 1-10 AFB per field are seen in at 
least 500 fields. 
(3+): means more than 10 AFB per field are 
seen in at least 20 fields 
The Erythrocyte Sedimentation Rate (ESR) of 
each patient was determined by Westergen-micro 
method using EDTA anticoagulated blood and 
the reading was taken at the end of one hour. The 




A total number of one hundred and thirty two 
(132) individuals attending outpatient clinic at 
Sacred Heart Hospital and State General 
Hospital, Ijaiye in Abeokuta participated in this 
study. Out of the total number 72(54.5%) were 
males while 60(45.5%) were females. 
The highest number of patients were in the age 
group 21-40 years, 64(48.5%) and the least in the 
age group 61-81 years, 10(7.6%). The prevalence 
of Mycobacterium tuberculosis infection in relation 
to age is shown table 2. The most infected 
individuals were seen in the age group 21-40 
years, 15(11.4%) while the least infected 
individuals were seen in the age group 61-81 
years, 1(8.0%). Age did not contribute 
significantly to mycobacteria infection. (P= 6.752)  
       
TABLE 2: MYCOBACTERIUM TUBERCULOSIS INFECTION IN RELATION TO AGE 
Age (year) Total number 
examined (%) 
Mycobacterium tuberculosis infection 
Positive (%) Negative (%) 
0-20 18 (13.6) 4 (3.0) 14 (10.6) 
21-40 64 (48.5) 15 (11.4) 49 (37.1) 
41-60 40 (30.3) 2 (1.5) 38 (28.8) 
61-81 10 (7.6) 1 (8.0) 9 (6.8) 
Total 132 (100.0) 22 (16.7) 110 (83.3) 
X2= 6.752       P= 0.080 
 
Table 3, Showed that the overall prevalence of M. 
tuberculosis was 22(16.7%) of which 14(10.6%) 
were males and 8(6.1%) were females.  Sex did 
not contribute significantly to M. tuberculosis 
infection ( P= 0.880) 
Table 5 Showed the results of the cross-tabulation 
between M.tuberculosis infection and 
Erythrocyte Sedimentation Rate (ESR). It showed 
that none of the patient with M. tuberculosis 
infection had normal Erythrocyte Sedimentation 
Rate (2-10mm/hr). ESR is significantly affected 









TABLE 3: MYCOBACTERIUM TUBERCULOSIS INFECTION IN RELATION TO SEX 
Sex Total number 
examined (%) 
Mycobacterium tuberculosis infection 
Positive (%) Negative (%) 
Male 72 (54.5) 14 (10.6) 58 (43.9) 
Female 60 (45.5) 8 (6.1) 52 (39.4) 
Total 132 (100.0) 22 (16.7) 110 (83.3) 
X2= 0.880    P= 0.348 
 
TABLE 4: MYCOBACTERIUM TUBERCULOSIS INFECTION IN RELATION TO PCV (PACKED CELL VOLUME) 
PCV (Range) Total number 
examined (%) 
Mycobacterium tuberculosis infection 
Positive (%) Negative (%) 
Normal (35-54) 94 (71.2) 0 (0.0) 94 (71.2) 
Moderate (26-34) 21 (15.9) 5 (3.8) 16 (12.1) 
Severe (< 26) 17 (12.9) 17 (12.9) 0 (0.0) 
Total 132 (100.0) 22 (16.7) 110 (83.3) 
X2= 95.895    P= 0.001 
 
TABLE 5: MYCOBACTERIUM TUBERCULOSIS INFECTION IN RELATION TO ESR (ERYTHROCYTE SEDIMENTATION RATE) 
ESR Total number examined 
(%) 
Mycobacterium tuberculosis infection 
Positive (%) Negative (%) 
2-10 107 (81.1) 0 (0.0) 107 (81.1) 
11-40 5 (3.8) 2 (1.5) 3 (2.3) 
41-70 9 (6.8) 9 (6.8) 0 (0.0) 
71-100 11 (8.3) 11 (8.3) 0 (0.0) 
Total 132 (100) 22 (16.7) 110 (83.3) 
X2= 112.218    P= 0.001 
 
DISCUSSION 
This study showed an overall prevalence of 
16.7% of Mycobacterium tuberculosis infection 
among patients in Abeokuta, Ogun State, South–
Western Nigeria. In another study in  Abeokuta, 
South-western Nigeria3 a lower prevalence of M. 
tuberculosis among HIV pregnant women 
attending antenatal clinics and Onifade et al in 
Lagos, South-west, Nigeria also recorded a lower 
prevalence of M. tuberculosis infection although 
they employed mantoux test for screening.(16). 
In Maiduguri, Northern Nigeria, Ukwandu et al 
reported higher prevalence of M. tuberculosis 
infection (17). In Minna, Ibrahim et al. also 
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obtained a higher prevalence of M. tuberculosis 
and Okodua et al. obtained higher prevalence for 
TB-HIV co-infection in Edo State, Nigeria (18,19). 
Other states in Nigeria like Kano, Enugu, Borno, 
Plateau and Benue recorded prevalent rates of 
12.0, 14.0, 27.0, 30.0 and 35.0% respectively (20). 
There was a higher prevalence rate in males 
(10.6%) when compared to females (6.1%). This 
higher rate could be due to higher exposure to 
HIV infection which inadvertently predisposed 
more of the affected males to TB disease. Though 
results of this study show that there was no 
significant difference between the sex and M. 
tuberculosis infection. This supports the report of 
Nwachukwu et al15. Although the highest rate of 
infection was among the age group 21-40 years, 
there was no significant difference between age 
group and M. tuberculosis infection for this study. 
This is in agreement with the previous report of 
Lawn et al (21). The lowest rate of infection in age  
 
group 61-81 may be due to diminished social 
habits. In the report of Campbell et al. which is 
similar to this study, M. tuberculosis infection 
significantly caused extreme increase in 
erythrocyte sedimentation rate (ESR). Studies 
also carried out by Ojo et al. supports this finding 
3). 
This study has been able to determine sputum 
smear positivity amongst patients who attended 
tuberculosis diagnosis and treatment clinics in 
Abeokuta. The infection was observed to affect 
mostly the economically supportive group of the 
society. The outcome of this project revealed that 
the prevalence of tuberculosis has been on 
decreasing side and the previous report of Ojo et 
al.3 lend credence to this study. 
CONCLUSION 
In conclusion more enlightenment campaigns 
should be carried out in the state to help curtail 
the infection. The control of tuberculosis 
therefore should involve the government at all 
levels. 
RECOMMENDATION 
We recommend that improved diagnostic 
facilities be deployed to various tertiary and 
secondary health facilities for rapid diagnosis of 
TB and also susceptibility testing for Multidrug 
resistant tuberculosis.  
International collaborations with low resource 
countries where TB is rampant should be 
established so that personnel can be trained to 
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